Literature DB >> 3054427

Drug-induced sexual dysfunction.

D E McWaine1, W R Procci.   

Abstract

A large body of data, as well as clinical experience, link prescribed medications and substances of abuse with sexual dysfunction. This review surveys the relevant literature and summarises key points relating various classes of medications and their possible sexual side effects. Surprisingly, there were very few carefully designed, well organised, systematic studies of the effects of medication upon sexual performance. The preponderance of data is in the form of either case studies or collections of patient reports of side effects. As a result, there are great variations in the reported rates of sexual disturbances associated with the administration of a given medication. A further difficulty is the lack of precision in the use of terms which describe the various sexual disorders. A final problem is the almost total lack of data concerning both disordered and normal sexual functioning in females.

Entities:  

Mesh:

Year:  1988        PMID: 3054427     DOI: 10.1007/bf03259941

Source DB:  PubMed          Journal:  Med Toxicol Adverse Drug Exp        ISSN: 0113-5244


  100 in total

1.  Cyproheptadine for imipramine-induced anorgasmia.

Authors:  T E Steele; E F Howell
Journal:  J Clin Psychopharmacol       Date:  1986-10       Impact factor: 3.153

2.  Clonidine: a new antihypertensive agent.

Authors:  G Onesti; K D Bock; V Heimsoth; K E Kim; P Merguet
Journal:  Am J Cardiol       Date:  1971-07       Impact factor: 2.778

3.  [State of spermatogenesis and sexual function in alcoholic abuse].

Authors:  N S Neshkov
Journal:  Vrach Delo       Date:  1969-02

Review 4.  Drug-induced sexual dysfunction and infertility.

Authors:  L Beeley
Journal:  Adverse Drug React Acute Poisoning Rev       Date:  1984

5.  Inhibited female orgasm as a side effect of alprazolam.

Authors:  R Sangal
Journal:  Am J Psychiatry       Date:  1985-10       Impact factor: 18.112

6.  National rates and patterns of consumption of antihypertensive drugs in relation to their availability in the United States, the United Kingdom, Australia and New Zealand.

Authors:  S R Petursson; W M Wardell; J P Curran
Journal:  Ann N Y Acad Sci       Date:  1978-03-30       Impact factor: 5.691

Review 7.  Sex and drugs.

Authors:  D J Munjack
Journal:  Clin Toxicol       Date:  1979       Impact factor: 4.467

8.  Propranolol and Peyronie's disease.

Authors:  A A Wallis; R Bell; P W Sutherland
Journal:  Lancet       Date:  1977-11-05       Impact factor: 79.321

9.  Effects of methyldopa in fifty hypertensive patients.

Authors:  D Horwitz; W A Pettinger; H Orvis; R E Thomas; A Sjoerdsma
Journal:  Clin Pharmacol Ther       Date:  1967 Mar-Apr       Impact factor: 6.875

10.  A clinical guide to the diagnosis and treatment of heroin-related sexual dysfunction.

Authors:  D E Smith; C Moser; D R Wesson; M Apter; M E Buxton; J V Davison; M Orgel; J Buffum
Journal:  J Psychoactive Drugs       Date:  1982 Jan-Jun
View more
  2 in total

1.  Transient sexual dysfunction observed during antiarrhythmic therapy by long-acting disopyramide in a male Wolff-Parkinson-White patient.

Authors:  J Hasegawa; H Mashiba
Journal:  Cardiovasc Drugs Ther       Date:  1994-04       Impact factor: 3.727

Review 2.  Drug-induced male sexual dysfunction. An update.

Authors:  G B Brock; T F Lue
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.